PL3528801T3 - Kompozycje i sposoby zastosowania beta-hydroksy-beta-metylomaślanu (hmb) i probiotyków - Google Patents
Kompozycje i sposoby zastosowania beta-hydroksy-beta-metylomaślanu (hmb) i probiotykówInfo
- Publication number
- PL3528801T3 PL3528801T3 PL17862326.0T PL17862326T PL3528801T3 PL 3528801 T3 PL3528801 T3 PL 3528801T3 PL 17862326 T PL17862326 T PL 17862326T PL 3528801 T3 PL3528801 T3 PL 3528801T3
- Authority
- PL
- Poland
- Prior art keywords
- beta
- hmb
- methylbutyrate
- probiotics
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662411200P | 2016-10-21 | 2016-10-21 | |
| PCT/US2017/057549 WO2018075867A1 (en) | 2016-10-21 | 2017-10-20 | COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE (HMB) AND PROBIOTICS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3528801T3 true PL3528801T3 (pl) | 2025-02-03 |
Family
ID=61971325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17862326.0T PL3528801T3 (pl) | 2016-10-21 | 2017-10-20 | Kompozycje i sposoby zastosowania beta-hydroksy-beta-metylomaślanu (hmb) i probiotyków |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180110745A1 (pl) |
| EP (1) | EP3528801B1 (pl) |
| JP (1) | JP7583523B2 (pl) |
| CN (1) | CN110167544A (pl) |
| AU (2) | AU2017345598B2 (pl) |
| CA (1) | CA3041520A1 (pl) |
| DK (1) | DK3528801T3 (pl) |
| ES (1) | ES2996841T3 (pl) |
| FI (1) | FI3528801T3 (pl) |
| HU (1) | HUE069527T2 (pl) |
| PL (1) | PL3528801T3 (pl) |
| PT (1) | PT3528801T (pl) |
| WO (1) | WO2018075867A1 (pl) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028440A (en) | 1990-01-30 | 1991-07-02 | Iowa State University Research Foundation, Inc. | Method of raising meat producing animals to increase lean tissue development |
| US4992470A (en) | 1990-02-08 | 1991-02-12 | Iowa State University Research Foundation, Inc. | Method of enhancing immune response of mammals |
| ES2142353T3 (es) | 1992-09-16 | 2000-04-16 | Univ Iowa State Res Found Inc | Procedimiento para reducir los niveles de colesterol total y de colesterol asociado a lipoproteinas de baja densidad en sangre. |
| US5348979A (en) | 1992-12-23 | 1994-09-20 | Iowa State University Research Foundation Inc. | Method of promoting nitrogen retention in humans |
| US6031000A (en) | 1998-06-23 | 2000-02-29 | Iowa State University Research Foundation, Inc. | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| JP5031717B2 (ja) * | 2008-12-03 | 2012-09-26 | 株式会社ユーグレナ | プリン体吸収抑制剤 |
| EP2381784B1 (en) * | 2008-12-09 | 2018-07-11 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
| PT2512236T (pt) | 2009-12-18 | 2016-12-29 | Metabolic Tech Inc | Método aperfeiçoado de administração de beta-hidroxi-beta-metilbutirato (hmb) |
| WO2014099904A1 (en) * | 2012-12-17 | 2014-06-26 | Abbott Laboratories | Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject |
| BR112015022757A2 (pt) * | 2013-03-15 | 2017-07-18 | Abbott Lab | composições nutricionais que incluem beta-hidróxi-beta-metilbutirato de cálcio, fosfopeptídeo de caseína, e proteína |
| US9844531B2 (en) * | 2013-03-15 | 2017-12-19 | Abbott Laboratories | Methods of maintaining and improving muscle function |
| CN105407744A (zh) * | 2013-03-15 | 2016-03-16 | 雅培制药有限公司 | 含有β-羟基-β-甲基丁酸的低卡路里婴儿配方 |
| US9585876B2 (en) * | 2013-03-15 | 2017-03-07 | Nusirt Sciences, Inc. | Leucine and nicotinic acid reduces lipid levels |
| MX2015015178A (es) | 2013-05-01 | 2016-02-26 | Abbott Lab | Metodos para potenciar la regeneracion de musculos envejecidos. |
| WO2015105981A2 (en) * | 2014-01-09 | 2015-07-16 | Abbott Laboratories | Conditional essentiality of hmb |
-
2017
- 2017-10-20 PL PL17862326.0T patent/PL3528801T3/pl unknown
- 2017-10-20 CA CA3041520A patent/CA3041520A1/en not_active Abandoned
- 2017-10-20 ES ES17862326T patent/ES2996841T3/es active Active
- 2017-10-20 AU AU2017345598A patent/AU2017345598B2/en active Active
- 2017-10-20 WO PCT/US2017/057549 patent/WO2018075867A1/en not_active Ceased
- 2017-10-20 JP JP2019521016A patent/JP7583523B2/ja active Active
- 2017-10-20 DK DK17862326.0T patent/DK3528801T3/da active
- 2017-10-20 US US15/789,104 patent/US20180110745A1/en not_active Abandoned
- 2017-10-20 HU HUE17862326A patent/HUE069527T2/hu unknown
- 2017-10-20 FI FIEP17862326.0T patent/FI3528801T3/fi active
- 2017-10-20 PT PT178623260T patent/PT3528801T/pt unknown
- 2017-10-20 EP EP17862326.0A patent/EP3528801B1/en active Active
- 2017-10-20 CN CN201780075087.0A patent/CN110167544A/zh active Pending
-
2023
- 2023-11-14 AU AU2023266257A patent/AU2023266257A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017345598B2 (en) | 2023-11-30 |
| EP3528801B1 (en) | 2024-07-17 |
| EP3528801A1 (en) | 2019-08-28 |
| FI3528801T3 (fi) | 2024-10-24 |
| EP3528801A4 (en) | 2020-07-15 |
| WO2018075867A1 (en) | 2018-04-26 |
| DK3528801T3 (da) | 2024-10-14 |
| US20180110745A1 (en) | 2018-04-26 |
| CA3041520A1 (en) | 2018-04-26 |
| JP7583523B2 (ja) | 2024-11-14 |
| AU2017345598A1 (en) | 2019-05-16 |
| JP2019531748A (ja) | 2019-11-07 |
| HUE069527T2 (hu) | 2025-03-28 |
| CN110167544A (zh) | 2019-08-23 |
| PT3528801T (pt) | 2024-10-21 |
| AU2023266257A1 (en) | 2023-12-07 |
| ES2996841T3 (en) | 2025-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274276A (en) | CASZ preparations and methods of use | |
| GB2582100B (en) | CAS12C Compositions and methods of use | |
| ZA201801511B (en) | Flavonoid compositions and methods of use | |
| IL257307B (en) | Transgenic crispr–cas9 preparations and methods of use | |
| ZA201805805B (en) | Formulations and methods | |
| ZA201906169B (en) | Synthekine compositions and methods of use | |
| ZA202104969B (en) | Compositions comprising 15-hepe and methods of using the same | |
| IL285928A (en) | Fulvestrant formulations and methods of using them | |
| PT3380525T (pt) | Formulações farmacêuticas e métodos que as utilizam | |
| PL3288379T3 (pl) | Kompozycje peptydowe i sposoby stosowania | |
| IL266132B (en) | Pharmaceutical formulations and methods for their preparation | |
| IL263349A (en) | Compositions of polyalkylene oxide-asparaginase and methods for their preparation and use | |
| IL274563A (en) | Methods of use and preparations containing dolaglutide | |
| GB2591422B (en) | Maca compositions and methods of use | |
| EP3253396A4 (en) | Probiotic compositions and methods of use | |
| PT3503885T (pt) | Composição farmacêutica e métodos de utilização | |
| GB201621737D0 (en) | Compositions and methods of treatment | |
| IL261794A (en) | Preparations and methods for using them | |
| SG11202002351SA (en) | Poloxamer compositions and methods of making and using same | |
| PT3528801T (pt) | Composições e métodos de utilização de beta-hidroxi-beta-metilbutirato (hmb) e probióticos | |
| HK1260777A1 (en) | Devices and compositions and methods of use thereof | |
| ZA201606358B (en) | Compositions of selenoorganic compounds and methods and methods of use thereof |